Yahoo
Tokyo - Delayed Quote JPY

Tsuruha Holdings Inc. (3391.T)

2,236.00 +52.00 (+2.38%)
At close: October 30 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 3391.T
  • Previous Close 2,184.00
  • Open 2,218.50
  • Bid 2,235.00 x --
  • Ask 2,237.00 x --
  • Day's Range 2,200.00 - 2,269.00
  • 52 Week Range 1,889.00 - 2,993.00
  • Volume 1,800,700
  • Avg. Volume 1,831,875
  • Market Cap (intraday) 1.015T
  • Beta (5Y Monthly) 0.20
  • PE Ratio (TTM) 17.55
  • EPS (TTM) 127.41
  • Earnings Date Jan 8, 2027
  • Forward Dividend & Yield 48.00 (2.15%)
  • Ex-Dividend Date Feb 25, 2027
  • 1y Target Est 2,613.33

Tsuruha Holdings Inc., together with its subsidiaries, operates drugstores in Japan. The company sells pharmaceutical, cosmetic, miscellaneous goods and food products. It is also involved in group support business; provision of Tsuruha drug care services, wellness care center, and lady care shop active; and overseas business. The company was founded in 1929 and is headquartered in Sapporo, Japan.

www.tsuruha-hd.co.jp

27,681

Full Time Employees

February 28

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

3391.T
20.85%
Nikkei 225 (^N225)
25.73%

1-Year Return

3391.T
14.58%
Nikkei 225 (^N225)
23.31%

3-Year Return

3391.T
14.12%
Nikkei 225 (^N225)
106.18%

5-Year Return

3391.T
9.00%
Nikkei 225 (^N225)
119.05%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 638.63B
Earnings 16.77B
Profit Margin 2.63%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
200B
400B
600B
2.2%
2.3%
2.4%
2.5%
2.6%

Analyst Insights

View More

Analyst Price Targets

2,150.00
2,613.33 Average
2,236.00 Current
3,050.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.42%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.17T

  • Net Income Avi to Common (ttm)

    52.56B

  • Diluted EPS (ttm)

    127.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    141.44B

  • Total Debt/Equity (mrq)

    21.91%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: